Alpha 2.0
Login Register
» Authors » Yosuke Nishihata

Yosuke Nishihata

Explore the profile of Yosuke Nishihata including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 225
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Psychiatry
Top 10 Co-Authors
Yasuyuki Shiraishi
Tsutomu Yoshikawa
Ayumi Goda
Takashi Kohno
Shun Kohsaka
Yuji Nagatomo
Makoto Takei
Mike Saji
Shintaro Nakano
Nobuyuki Komiyama
Published In
ESC Heart Fail
J Clin Med
Biol Psychiatry
Respir Med
Sci Rep
Affiliations
Soon will be listed here.
Recent Articles
1.
Synaptic alterations in pyramidal cells following genetic manipulation of neuronal excitability in monkey prefrontal cortex
Gonzalez Burgos G, Gonzalez-Burgos G, Miyamae T, Nishihata Y, Krimer O, Wade K, et al.
J Neurophysiol . 2024 Dec; 133(2):399-413. PMID: 39740351
The primate dorsolateral prefrontal cortex (DLPFC) displays unique in vivo activity patterns, but how in vivo activity regulates DLPFC pyramidal neuron (PN) properties remains unclear. We assessed the effects of...
2.
Early initiation of oral beta-blocker improves long-term survival in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention
Dai Z, Nishihata Y, Urayama K, Komiyama N
BMC Cardiovasc Disord . 2024 Sep; 24(1):511. PMID: 39327569
Background: The optimal timing for the initiation of oral beta-blockers after acute myocardial infarction (MI) remains unclear within the context of current primary percutaneous coronary intervention (PCI) practice. Methods: This...
3.
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump - insights from J-PVAD
Suzuki T, Asano T, Yoneoka D, Ono M, Miyata K, Kanie T, et al.
EuroIntervention . 2024 Aug; 20(16):987-995. PMID: 39155754
Background: ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock (STEMI-CS) is associated with high mortality rates. Patients admitted during off-hours, specifically on weekends and at night, show higher mortality...
4.
Synaptic alterations in pyramidal cells following genetic manipulation of neuronal excitability in monkey prefrontal cortex
Gonzalez Burgos G, Miyamae T, Nishihata Y, Krimer O, Wade K, Fish K, et al.
bioRxiv . 2024 Jun; PMID: 38915638
Significance Statement: In schizophrenia, dorsolateral prefrontal cortex (DLPFC) pyramidal neurons (PNs) have both transcriptional and structural alterations that suggest they are hypoactive. PN hypoactivity is thought to produce synaptic alterations...
5.
NARP-related alterations in the excitatory and inhibitory circuitry of socially isolated mice: developmental insights and implications for autism spectrum disorder
Yamaguchi Y, Okamura K, Yamamuro K, Okumura K, Komori T, Toritsuka M, et al.
Front Psychiatry . 2024 Jun; 15:1403476. PMID: 38903649
Background: Social isolation during critical periods of development is associated with alterations in behavior and neuronal circuitry. This study aimed to investigate the immediate and developmental effects of social isolation...
6.
Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial
Asano T, Tanigaki T, Hoshino M, Yasunaga M, Nonaka H, Emori H, et al.
EuroIntervention . 2024 May; 20(9):561-570. PMID: 38726719
Background: Vessel-level physiological data derived from pressure wire measurements are one of the important determinant factors in the optimal revascularisation strategy for patients with multivessel disease (MVD). However, these may...
7.
Clinical efficacy of tolvaptan in acute decompensated heart failure patients with severe aortic stenosis and atrial fibrillation: a sub-analysis from the LOHAS registry
Murakami T, Watanabe Y, Nakamura N, Natsumeda M, Ohno Y, Nakazawa G, et al.
Heart Vessels . 2024 May; 39(8):687-695. PMID: 38710808
Background: Severe aortic valve stenosis (AS) and atrial fibrillation (AF) are risk factors of hemodynamic instability in heart failure (HF) management due to low cardiac output, respectively. Therefore, the treatment...
8.
Strength of Excitatory Inputs to Layer 3 Pyramidal Neurons During Synaptic Pruning in the Monkey Prefrontal Cortex: Relevance for the Pathogenesis of Schizophrenia
Gonzalez-Burgos G, Miyamae T, Nishihata Y, Krimer O, Lewis D
Biol Psychiatry . 2023 Feb; 94(4):288-296. PMID: 36736420
Background: In schizophrenia, layer 3 pyramidal neurons (L3PNs) of the dorsolateral prefrontal cortex exhibit deficits in markers of excitatory synaptic inputs that are thought to disrupt the patterns of neural...
9.
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
Sakuma M, Iimuro S, Shinozaki T, Kimura T, Nakagawa Y, Ozaki Y, et al.
BMC Med . 2022 Nov; 20(1):441. PMID: 36372869
Background: Aggressive lipid lowering by high-dose statin treatment has been established for the secondary prevention of coronary artery disease (CAD). Regarding the low-density lipoprotein cholesterol (LDL-C) level, however, the "The...
10.
Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary Artery Disease　- An Observation From the REAL-CAD Study
Toyota T, Morimoto T, Iimuro S, Fujita R, Iwata H, Miyauchi K, et al.
Circ J . 2022 Sep; 87(2):360-367. PMID: 36104250
Background: The relationship between very low on-treatment low-density lipoprotein cholesterol (LDL-C) level and cardiovascular event risk is still unclear in patients receiving the same doses of statins. Methods and results:...